Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FY22S
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,021
Award facts
- Contract value 100% obligated
- $5,021.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,021.26 by the Defense Logistics Agency (DLA) on August 12, 2025. The contract calls for the delivery of EXPAREL 266 mg/20 mL vials, a local anesthetic medication used in surgical and pain management applications. The delivery order was issued without a set-aside designation and carries an ultimate completion date of September 3, 2025, with performance to be completed at the vendor's Park Ridge, Illinois location.
This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499,999,999 and valid through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for pharmaceutical products supporting the medical supply needs of military healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a key supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively for contracts that provide prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites across the globe.
Quick answers
Who was awarded contract SPE2DB25FY22S?
SPE2DB25FY22S was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FY22S worth?
The government has obligated $5,021 on SPE2DB25FY22S.
Is contract SPE2DB25FY22S an order under another contract?
Yes. SPE2DB25FY22S is a delivery order under SPE2DB22D9362, an indefinite delivery contract.
Was contract SPE2DB25FY22S competed?
The extent of competition for SPE2DB25FY22S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award